Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sreekanth Thota

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Protein & Peptide Science|January 23, 2016
Drug Discovery and Development of Antimalarial Agents: Recent AdvancesSreekanth Thota, Rajeshwar Yerra
Mini Reviews in Medicinal Chemistry|July 24, 2015
Drug Discovery for Paediatric Chagas DiseaseSreekanth Thota, Carlos M Morel
Mini Reviews in Medicinal Chemistry|July 24, 2015
Recent Advances in Synthetic Chemistry of Diabetic ResearchSreekanth Thota, Carlos M Morel
Mini Reviews in Medicinal Chemistry|February 23, 2018
Recent Advances in Development of Polyphenols as Anticancer AgentsSreekanth Thota, Daniel Alencar Rodrigues, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry|April 29, 2016
Beyond the Selective Inhibition of Histone Deacetylase 6Daniel A Rodrigues, Sreekanth Thota, Carlos A M Fraga
Journal of Medicinal Chemistry|February 16, 2018
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?Sreekanth Thota, Daniel A Rodrigues, Debbie C Crans, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Novel mononuclear ruthenium(II) compounds in cancer therapyShyam Sunder Anchuri, Sreekanth Thota, Rajeshwar Yerra, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compoundsSubhas S Karki, Sreekanth Thota, Satyanarayana Y Darj, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 5, 2010
Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexesSreekanth Thota, Subhas S Karki, K N Jayaveera, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|August 10, 2013
Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compoundsShyam Sunder A, Satyavati Dhulipala, Sreekanth Thota, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Protein & Peptide Science|January 23, 2016
Drug Discovery and Development of Antimalarial Agents: Recent AdvancesSreekanth Thota, Rajeshwar Yerra
Mini Reviews in Medicinal Chemistry|July 24, 2015
Drug Discovery for Paediatric Chagas DiseaseSreekanth Thota, Carlos M Morel
Mini Reviews in Medicinal Chemistry|July 24, 2015
Recent Advances in Synthetic Chemistry of Diabetic ResearchSreekanth Thota, Carlos M Morel
Mini Reviews in Medicinal Chemistry|February 23, 2018
Recent Advances in Development of Polyphenols as Anticancer AgentsSreekanth Thota, Daniel Alencar Rodrigues, Eliezer J Barreiro
Mini Reviews in Medicinal Chemistry|April 29, 2016
Beyond the Selective Inhibition of Histone Deacetylase 6Daniel A Rodrigues, Sreekanth Thota, Carlos A M Fraga
Journal of Medicinal Chemistry|February 16, 2018
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?Sreekanth Thota, Daniel A Rodrigues, Debbie C Crans, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Novel mononuclear ruthenium(II) compounds in cancer therapyShyam Sunder Anchuri, Sreekanth Thota, Rajeshwar Yerra, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compoundsSubhas S Karki, Sreekanth Thota, Satyanarayana Y Darj, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 5, 2010
Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexesSreekanth Thota, Subhas S Karki, K N Jayaveera, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|August 10, 2013
Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compoundsShyam Sunder A, Satyavati Dhulipala, Sreekanth Thota, et al.
Pageof 2